HRP20191746T1 - Stabilizirani desmopresin - Google Patents

Stabilizirani desmopresin Download PDF

Info

Publication number
HRP20191746T1
HRP20191746T1 HRP20191746TT HRP20191746T HRP20191746T1 HR P20191746 T1 HRP20191746 T1 HR P20191746T1 HR P20191746T T HRP20191746T T HR P20191746TT HR P20191746 T HRP20191746 T HR P20191746T HR P20191746 T1 HRP20191746 T1 HR P20191746T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparation
gum
acceptable salt
desmopressin
pharmaceutically acceptable
Prior art date
Application number
HRP20191746TT
Other languages
English (en)
Croatian (hr)
Inventor
Bong Sang Lee
Su-Jun Park
Jiyeong HAN
Myeongcheol KIL
Min Seop Kim
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53510836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20191746(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HRP20191746T1 publication Critical patent/HRP20191746T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20191746TT 2014-06-16 2015-06-15 Stabilizirani desmopresin HRP20191746T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020140073067A KR20150144209A (ko) 2014-06-16 2014-06-16 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물
PCT/EP2015/063347 WO2015193246A1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin
EP15734080.3A EP3154516B1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin

Publications (1)

Publication Number Publication Date
HRP20191746T1 true HRP20191746T1 (hr) 2019-12-27

Family

ID=53510836

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191746TT HRP20191746T1 (hr) 2014-06-16 2015-06-15 Stabilizirani desmopresin

Country Status (33)

Country Link
US (1) US20170128521A1 (enExample)
EP (1) EP3154516B1 (enExample)
JP (1) JP6615130B2 (enExample)
KR (2) KR20150144209A (enExample)
CN (1) CN106456706B (enExample)
AR (1) AR100850A1 (enExample)
AU (1) AU2015276247C1 (enExample)
CA (1) CA2951768C (enExample)
CL (1) CL2016003219A1 (enExample)
CO (1) CO2017000354A2 (enExample)
DK (1) DK3154516T3 (enExample)
EA (1) EA032834B1 (enExample)
ES (1) ES2751600T3 (enExample)
HR (1) HRP20191746T1 (enExample)
HU (1) HUE045395T2 (enExample)
IL (1) IL249538A0 (enExample)
JO (1) JO3500B1 (enExample)
LT (1) LT3154516T (enExample)
MX (1) MX374540B (enExample)
MY (1) MY182781A (enExample)
NZ (1) NZ727388A (enExample)
PH (1) PH12016502527A1 (enExample)
PL (1) PL3154516T3 (enExample)
PT (1) PT3154516T (enExample)
RS (1) RS59449B1 (enExample)
SA (1) SA516380492B1 (enExample)
SG (2) SG11201609374YA (enExample)
SI (1) SI3154516T1 (enExample)
TN (1) TN2016000561A1 (enExample)
TW (1) TWI670070B (enExample)
UA (1) UA119776C2 (enExample)
WO (1) WO2015193246A1 (enExample)
ZA (1) ZA201608020B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003233118B8 (en) * 2002-05-07 2009-07-30 Ferring Bv Desmopressin in an orodispersible dosage form
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release

Also Published As

Publication number Publication date
MY182781A (en) 2021-02-05
TW201605464A (zh) 2016-02-16
ES2751600T3 (es) 2020-04-01
BR112016029417A8 (pt) 2021-06-29
DK3154516T3 (da) 2019-09-23
CA2951768C (en) 2022-08-30
AU2015276247B2 (en) 2019-09-12
AR100850A1 (es) 2016-11-02
AU2015276247A1 (en) 2017-02-02
IL249538A0 (en) 2017-02-28
US20170128521A1 (en) 2017-05-11
HUE045395T2 (hu) 2019-12-30
EP3154516B1 (en) 2019-09-04
UA119776C2 (uk) 2019-08-12
CA2951768A1 (en) 2015-12-23
SI3154516T1 (sl) 2019-11-29
JP6615130B2 (ja) 2019-12-04
CN106456706A (zh) 2017-02-22
EA032834B1 (ru) 2019-07-31
LT3154516T (lt) 2019-10-25
PL3154516T3 (pl) 2020-08-10
RS59449B1 (sr) 2019-11-29
CN106456706B (zh) 2020-07-14
PH12016502527B1 (en) 2017-04-10
KR20170020450A (ko) 2017-02-22
BR112016029417A2 (pt) 2017-08-22
SA516380492B1 (ar) 2021-02-03
TWI670070B (zh) 2019-09-01
EA201692556A1 (ru) 2017-04-28
EP3154516A1 (en) 2017-04-19
NZ727388A (en) 2021-07-30
MX374540B (es) 2025-03-06
TN2016000561A1 (en) 2018-04-04
JP2017523955A (ja) 2017-08-24
CL2016003219A1 (es) 2017-06-30
SG11201609374YA (en) 2017-01-27
WO2015193246A1 (en) 2015-12-23
JO3500B1 (ar) 2020-07-05
MX2016016635A (es) 2017-06-06
KR102360656B1 (ko) 2022-02-09
KR20150144209A (ko) 2015-12-24
ZA201608020B (en) 2020-05-27
PH12016502527A1 (en) 2017-04-10
CO2017000354A2 (es) 2017-03-31
AU2015276247C1 (en) 2020-02-06
SG10201811139UA (en) 2019-01-30
PT3154516T (pt) 2019-12-05

Similar Documents

Publication Publication Date Title
JP2019108388A5 (enExample)
HRP20230931T1 (hr) Kristalični oblici n-(4-(4-(ciklopropilmetil)piperazin-1-karbonil)fenil)kinolin-8-sulfonamida
JP2016532722A5 (enExample)
FI4088720T3 (fi) Rimegepantti cgrp-liittyviin häiriöihin
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
HRP20230616T1 (hr) Disperzivni pripravci
CN103815014A (zh) 一种天然大米保鲜剂的制备方法
SI2729130T1 (en) Combined formulations of darunavir
JP2016503058A5 (enExample)
HRP20240166T1 (hr) Postupak liječenja prader-willijevog sindroma
WO2015081904A3 (en) Polyurethaneurea solutions for compositions with active ingredients or fragrances
FR2999086B1 (fr) Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation
RU2016131211A (ru) Комбинированный лекарственный препарат для профилактики инфекций, передающихся половым путём
HRP20191746T1 (hr) Stabilizirani desmopresin
HRP20191050T1 (hr) Pripravak protiv virusnog konjunktivitisa koji sadrži jota-karagenan
FI3258920T3 (fi) Juomavesilääkkeenä käytettäväksi soveltuva kiinteä farmaseuttinen annosmuoto
RU2019105711A (ru) Фармацевтическая композиция, содержащая помалидомид
JP2017008001A5 (enExample)
WO2012147101A3 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
JP2017014164A5 (enExample)
HRP20211160T1 (hr) Kompozicije koje sadrže geraniol i suhi đumbir za uporabu u liječenju sindroma iritabilnog crijeva
JP2017001966A5 (enExample)
WO2020053658A3 (en) Non-aqueous chemotherapeutic solutions for oral dosage
AR114074A1 (es) Combinación farmacéutica que comprende tramadol clorhidrato de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor
HRP20211354T1 (hr) Tekuće kompozicije tiourilena